Investment Firm
Overview
Altheos was a biopharmaceutical company focused on the development of small molecule drugs.
Feb 09, 2012
Series A
Highlights
Location
Social
N/A
Investor Lead
N/A
Participant Investors
3
Investor Name |
---|
Novo Holdings |
Bay City Capital |
Canaan Partners |
Altheos raised $12500000 on 2012-02-09 in Series A
Altheos was a biopharmaceutical company focused on the development of small molecule drugs.
Company Funding History
2
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Feb 09, 2012 | Series A - Altheos | 3 | - | 12.5M |
Apr 05, 2010 | Series A - Altheos | 5 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.